Intermolecular Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Intermolecular are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Intermolecular has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Intermolecular is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Fifty Two Week Low | 0.9000 | |
| Target High Price | 1.20 | |
| Fifty Two Week High | 1.2500 | |
| Target Low Price | 1.20 |
Intermolecular |
Intermolecular Relative Risk vs. Return Landscape
If you would invest (100.00) in Intermolecular on March 7, 2024 and sell it today you would earn a total of 100.00 from holding Intermolecular or generate -100.0% return on investment over 90 days. Intermolecular is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Intermolecular, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Intermolecular Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intermolecular's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Intermolecular, and traders can use it to determine the average amount a Intermolecular's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IMI |
Based on monthly moving average Intermolecular is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intermolecular by adding Intermolecular to a well-diversified portfolio.
Intermolecular Fundamentals Growth
Intermolecular Stock prices reflect investors' perceptions of the future prospects and financial health of Intermolecular, and Intermolecular fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Intermolecular Stock performance.
| Return On Equity | 35.45 | |||
| Return On Asset | 12.76 | |||
| Profit Margin | 12.89 % | |||
| Operating Margin | (45.02) % | |||
| Current Valuation | 49.2 M | |||
| Shares Outstanding | 49.76 M | |||
| Price To Earning | (3.08) X | |||
| Price To Book | 2.15 X | |||
| Price To Sales | 2.35 X | |||
| Revenue | 25.45 M | |||
| EBITDA | (8.31 M) | |||
| Cash And Equivalents | 23.91 M | |||
| Cash Per Share | 0.48 X | |||
| Total Debt | 13.65 M | |||
| Debt To Equity | 49.10 % | |||
| Book Value Per Share | 0.85 X | |||
| Cash Flow From Operations | (6.01 M) | |||
| Earnings Per Share | (0.22) X | |||
| Total Asset | 69.68 M | |||
| Retained Earnings | (176.41 M) | |||
| Current Asset | 43.05 M | |||
| Current Liabilities | 10.24 M | |||
Things to note about Intermolecular performance evaluation
Checking the ongoing alerts about Intermolecular for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Intermolecular help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Intermolecular is not yet fully synchronised with the market data | |
| Intermolecular has some characteristics of a very speculative penny stock | |
| Intermolecular has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 25.45 M. Reported Net Loss for the year was (10.88 M) with profit before taxes, overhead, and interest of 23.65 M. | |
| Intermolecular has about 23.91 M in cash with (6.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Roughly 30.0% of the company shares are held by company insiders |
- Analyzing Intermolecular's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Intermolecular's stock is overvalued or undervalued compared to its peers.
- Examining Intermolecular's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Intermolecular's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Intermolecular's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Intermolecular's stock. These opinions can provide insight into Intermolecular's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Intermolecular Stock
If you are still planning to invest in Intermolecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intermolecular's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |